.FDA refuses experimental MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Permit MDMA Therapy, Finding Even More Research Study The Nyc TimesFDA Refuses Ecstasy-Based Drug The Commercial JournalFDA rejects to approve unfamiliar MDMA treatment to deal with post-traumatic stress disorder, with ask for additional trial data CNNFDA turns down to begin with psychedelic to deal with post-traumatic stress disorder, requiring more research The Washington Message.